Quality of Life After Sialendoscopy: Prospective Non-Randomized Study
| Autor: | Giulianno Molina Melo, Murilo Catafesta Neves, Marcello Rosano, Christiana Maria Ribeiro Salles Vanni, Marcio Abrahao, Onivaldo Cervantes |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Quality of life
medicine.medical_specialty RD1-811 Sialadenitis law.invention Iodine Radioisotopes Quality of life (healthcare) Randomized controlled trial law medicine Humans Prospective Studies Sialendoscopy Retrospective Studies Salivary Gland Calculi business.industry Research Sialoadenitis Endoscopy Salivary gland diseases General Medicine Treatment Outcome Salivary gland stones Physical therapy Female Surgery business |
| Zdroj: | BMC Surgery BMC Surgery, Vol 22, Iss 1, Pp 1-15 (2022) |
| DOI: | 10.21203/rs.3.rs-679845/v1 |
| Popis: | Background The symptomatic (swelling and pain) salivary gland obstructions are caused by sialolithiasis and salivary duct stenosis, negatively affecting quality of life (QOL), with almost all candidates for clinical measures and minimally invasive sialendoscopy. The impact of sialendoscopy treatment on the QOL has been little addressed nowadays. The objective is to prospectively evaluate the impact of sialendoscopy on the quality of life of patients undergoing sialendoscopy due to benign salivary obstructive diseases, measured through QOL questionnaires of xerostomia degree, the oral health impact profile and post sialendoscopy satisfaction questionnaires. Result 37 sialendoscopies were included, most young female; there were 64.5% sialolithiasis and 35.4% post-radioiodine; with 4.5 times/week painful swelling symptoms and 23.5 months symptom duration. The pre- and post-sialendoscopy VAS values were: 7.42 to 1.29 (p Conclusions We found improved symptoms with overall good satisfaction after sialendoscopy correlated with stones; and a negative correlation between xerostomia. Our findings support the evident indication of sialendoscopy for obstructive sialolithiasis with a positive impact on QOL and probably a relative time-dependent indication for stenosis/other xerostomia causes that little improved QOL satisfaction. Level of evidence 2b—Prospective non-randomized study. Trial registration: WHO Universal Trial Number (UTN): U1111-1247-7028; Brazilian Clinical Trials Registry (ReBeC): RBR-6p8zfs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|